Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,493,000 | 11,549,000 | 7,504,000 | 4,324,000 | 3,555,000 |
| Depreciation Amortization | 2,053,000 | 8,521,000 | 6,542,000 | 4,415,000 | 2,215,000 |
| Income taxes - deferred | -194,000 | -898,000 | -153,000 | -119,000 | -28,000 |
| Accounts receivable | -785,000 | -1,321,000 | -572,000 | -1,162,000 | -866,000 |
| Accounts payable and accrued liabilities | -258,000 | 1,719,000 | 1,454,000 | 308,000 | 236,000 |
| Other Working Capital | -1,147,000 | -1,444,000 | -423,000 | -1,976,000 | -976,000 |
| Other Operating Activity | 746,000 | 4,651,000 | 3,350,000 | 3,977,000 | 741,000 |
| Operating Cash Flow | $4,908,000 | $22,777,000 | $17,702,000 | $9,767,000 | $4,877,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -162,000 | -787,000 | -600,000 | -383,000 | -188,000 |
| Net Acquisitions | -185,000 | -1,902,000 | -837,000 | -345,000 | -198,000 |
| Purchase Of Investment | -1,406,000 | -119,000 | -73,000 | -56,000 | -16,000 |
| Sale Of Investment | 8,000 | 98,000 | 88,000 | 65,000 | 11,000 |
| Other Investing Activity | 154,000 | 366,000 | 223,000 | 135,000 | 49,000 |
| Investing Cash Flow | $-1,591,000 | $-2,344,000 | $-1,199,000 | $-584,000 | $-342,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,000,000 | 1,000,000 | 1,000,000 | 0 | 0 |
| Debt Repayment | -4,879,000 | -9,414,000 | -5,662,000 | -3,461,000 | 0 |
| Common Stock Issued | 128,000 | 244,000 | 169,000 | 144,000 | 71,000 |
| Common Stock Repurchased | -1,470,000 | -934,000 | -803,000 | -797,000 | -787,000 |
| Dividend Paid | -2,526,000 | -9,261,000 | -6,947,000 | -4,632,000 | -2,322,000 |
| Other Financing Activity | -225,000 | -674,000 | -458,000 | -312,000 | -136,000 |
| Financing Cash Flow | $-6,972,000 | $-19,039,000 | $-12,701,000 | $-9,058,000 | $-3,174,000 |
| Exchange Rate Effect | 7,000 | -97,000 | -69,000 | -28,000 | -55,000 |
| Beginning Cash Position | 9,746,000 | 8,449,000 | 8,449,000 | 8,449,000 | 8,449,000 |
| End Cash Position | 6,098,000 | 9,746,000 | 12,182,000 | 8,546,000 | 9,755,000 |
| Net Cash Flow | $-3,648,000 | $1,297,000 | $3,733,000 | $97,000 | $1,306,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,908,000 | 22,777,000 | 17,702,000 | 9,767,000 | 4,877,000 |
| Capital Expenditure | -162,000 | -787,000 | -600,000 | -383,000 | -188,000 |
| Free Cash Flow | 4,746,000 | 21,990,000 | 17,102,000 | 9,384,000 | 4,689,000 |